TITLE

Dabigatran Leading Race to Replace Warfarin

PUB. DATE
November 2010
SOURCE
Internal Medicine Alert;11/15/2010 Clinical, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses various reports published within the issue including one on the U.S. Food and Drug Administration (FDA) Advisory Committee's recommending approval of dabigatran, one on the safety of proton pump inhibitors, and one on the effectiveness of glucosamine and chondroitin as alternative treatment for osteoarthritis.
ACCESSION #
56577140

 

Related Articles

  • Dabigatran Leading Race to Replace Warfarin. Elliott, William T. // OB/GYN Clinical Alert;Nov2010 Pharmacology, p1 

    The article offers information on various topics related to drugs. It cites the possible approval of dabigatran, a thrombin inhibitor, by the U.S. Food and Drug Administration (FDA) as a preferred anticoagulant for patients with atrial fibrillation to replace warfarin. It also discusses studies...

  • Leadership Through Research. Kalman, Douglas // Nutraceuticals World;Jan/Feb2010, Vol. 13 Issue 1, p28 

    The article discusses the importance of validating dietary supplement products through scientific studies prior to marketing in the U.S. It focuses on the marketing of Elations, a liquid health product that delivers glucosamine and chondroitin, which is believed to relieve arthritis and is...

  • Are supplements really safe?  // Consumer Reports on Health;Jun2014, Vol. 26 Issue 6, p1 

    The article discusses research which has been conducted on several types of supplements, including vitamin E, multivitamins and omega-3 fatty acids, and has found that they are ineffective in treating health conditions or may pose health risks. A discussion of problems associated with...

  • Drug regulation and arthritis.  // Independent Nurse;10/18/2010, p1 

    The article focuses on various studies published in different journals regarding the side effects of drugs used for arthritis. One of the studies published in a previous issue of the "New England Journal" found that an increased risk of cardiovascular (CV) events is caused by the use of inhaled...

  • Prescription ads next on FDA list. Colford, S.W. // Advertising Age;8/26/91, Vol. 62 Issue 35, p32 

    Examines Food & Drug Administration (FDA) plans to tighten regulations on drug advertising and various promotional practices. Principal concerns of Commissioner David Kessler; Present regulations of consumer ads for prescription drugs.

  • Over-the-counter drugs. Sommi Jr., R.W. // Current Health 2;May92, Vol. 18 Issue 9, p21 

    Discusses the differences between prescription and nonprescription drugs (also called over-the-counter, or OTC, drugs). Role of the US Food and Drug Administration (FDA); OTC drugs for self-limiting illnesses such as the common cold; The FDA's concern about side effects, clear instructions and...

  • The FDA safeguarding. Kowalski, Kathiann M. // Current Health 2;Jan1996, Vol. 22 Issue 5, p20 

    Presents the work and duties of the Food and Drug Administration (FDA) in the United States. Origin of the agency; Rules followed on food standard inspection; Presence of food chemicals; Safety programs of FDA; Actions of the agency in the presence of problems; Nutrition labeling and Education...

  • Product testing.  // Current Health 1;May92, Vol. 15 Issue 9, p22 

    Discusses the medicine and product testing conducted by the US Food and Drug Administration (FDA). Pharmaceutical tests; How the FDA studies test results; FDA approval; Drug testing in other countries; Tests on food, cosmetics, pesticides; The FDA's concern about food labels; Testing donated blood.

  • Dateline Washington.  // Consumers' Research Magazine;Feb1993, Vol. 76 Issue 2, p6 

    Reports that in January a US District Court judge ruled that the Food and Drug Administration (FDA) is not responsible for $210 million worth of losses incurred by Chilean fruit growers when in 1989, the FDA temporarily banned sales of grapes to the United States. Details of the ruling.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics